Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.

将白血病细疗药物微孔液体培养，MTT法检测细毒性。

Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.

MRD为抗白血病药物疗效标志,被用于评估险,在某些病例中也用于调整治疗强度。